Expression of Toll-like receptor 4 in various organs in rats with d-galactosamine-induced acute hepatic failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 8 PART2, 2008, Pages

  Kitazawa, Toshiyuki ^a   Tsujimoto, Tatsuhiro ^a   Kawaratani, Hideto ^a   Fujimoto, Masao ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute hepatic failure; CD14; D galactosamine; Toll like receptor 4; Tumor necrosis factor alpha

Indexed keywords

BIOCHEMICAL MARKER; CD14 ANTIGEN; GALACTOSAMINE; MESSENGER RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LIVER FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

EID: 48549097439     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05246.x     Document Type: Article

References (22)

1. Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin. Liver Dis. 2003 23 : 203 15.
2. Romics L Jr, Dolganiuc A, Kodys K et al. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice. Hepatology 2004 40 : 555 64.
3. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006 130 : 1886 900.
4. Peng Y, Gong JP, Liu CA, Li XH, Gan L, Li SB. Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J. Gastroenterol. 2004 10 : 2890 3.
5. Takayashiki T, Yoshidome H, Kimura F et al. Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice. J. Hepatol. 2004 41 : 621 8.
6. Zhai Y, Shen XD, O'Connell R et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 2004 173 : 7115 9.
7. Gustot T, Lemmers A, Moreno C et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006 43 : 989 1000.
8. Leifeld L, Dumoulin FL, Purr I et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J. Pathol. 2003 199 : 335 44.
9. Alcorn JM, Fierer J, Chojkier M. The acute-phase response protects mice from d-galactosamine sensitization to endotoxin and tumor necrosis factor-alpha. Hepatology 1992 15 : 122 9.
10. Diaz-Buxo JA, Blumenthal S, Hayes D, Gores P, Gordon B. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology 1997 25 : 950 7.
11. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 2003 85 : 85 95.
12. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med. (Maywood) 2003 228 : 882 90.
13. Streetz K, Leifeld L, Grundmann D et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000 119 : 446 60.
14. Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D. Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am. J. Physiol. 1995 269 : G297 304.
15. Wang H, Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. Eur. J. Pharmacol. 2006 534 : 194 201.
16. Camara DS, Caruana JA Jr, Schwartz KA, Montes M, Nolan JP. D-Galactosamine liver injury: absorption of endotoxin and protective effect of small bowel and colon resection in rabbits. Proc. Soc. Exp. Biol. Med. 1983 172 : 255 9.
17. Czaja MJ, Xu J, Ju Y, Alt E, Schmiedeberg P. Lipopolysaccharide- neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration. Hepatology 1994 19 : 1282 9.
18. Sakaguchi S, Furusawa S, Yokota K, Sasaki K, Takayanagi M, Takayanagi Y. Role of endogenous endotoxin on tumor necrosis factor-hypersensitivity caused by d-galactosamine challenge. Biol. Pharm. Bull. 2000 23 : 116 8.
19. Liehr H, Grun M, Seelig HP, Seelig R, Reutter W, Heine WD. On the pathogenesis of galactosamine hepatitis. Indications of extrahepatocellular mechanisms responsible for liver cell death. Virchows Arch. B Cell Pathol. 1978 26 : 331 44.
20. Masubuchi Y, Horie T. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug Metab. Dispos. 2004 32 : 437 41.
21. Grun M, Liehr H, Rasenack U. Significance of endotoxaemia in experimental 'galactosamine-hepatitis' in the rat. Acta Hepatogastroenterol. (Stuttg.) 1977 24 : 64 81.
22. Cornell RP. Endotoxin-induced hyperinsulinemia and hyperglucagonemia after experimental liver injury. Am. J. Physiol. 1981 241 : E428 35.